Glioblastoma: all 1,951 studies
Page 4 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in GlioblastomaRecruitingNCT05941234Not applicable
- Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade GliomaRecruitingNCT05929495Phase 2
- Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)RecruitingNCT05929456Phase 1
- New Antigens Against GlioblastomaNot yet recruitingNCT05917821
- ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade GliomaRecruitingNCT05917145Phase 1
- Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent GlioblastomaRecruitingNCT05914935Early Phase 1
- Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain MetastasesRecruitingNCT05911230Not applicable
- Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma MultiformeEnrolling by invitationNCT05908669
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III StudyRecruitingNCT05904119Phase 3
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMRecruitingNCT05902169Phase 3
- Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaRecruitingNCT05879367Phase 1
- WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaRecruitingNCT05879250Phase 2
- The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent GlioblastomaRecruitingNCT05868083Phase 1
- Neurosurgical Neuronavigation Using Resting State MRI and Machine LearningRecruitingNCT05864976
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantRecruitingNCT05843253Phase 2
- Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed GlioblastomaNot yet recruitingNCT05842746Phase 2
- Targeted Pediatric High-Grade Glioma TherapyRecruitingNCT05839379
- B-amyloid as a Marker for GBM BioimagingNot yet recruitingNCT05820191Phase 2
- Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.Not yet recruitingNCT05811793Not applicable
- A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on GlioblastomaNot yet recruitingNCT05802693Early Phase 1
- FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI PhenotypeRecruitingNCT05793021Not applicable
- Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing CraniotomyRecruitingNCT05789394Phase 1
- Glutamate Excitotoxicity and Its Role in Glioblastoma BiologyRecruitingNCT05775458
- A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)RecruitingNCT05769660Phase 1
- Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade GliomasRecruitingNCT05768919Phase 1/2
- Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma PatientsRecruitingNCT05768087Not applicable
- A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaRecruitingNCT05765812Phase 1/2
- Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain TissueRecruitingNCT05756985
- D2C7-IT and 2141-V11 in Newly Diagnosed GBM PatientsRecruitingNCT05734560Phase 1/2
- Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma PatientsNot yet recruitingNCT05728125
- A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care TreatmentRecruitingNCT05708352Phase 2
- A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaRecruitingNCT05698524Phase 1
- Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.RecruitingNCT05686798Phase 1
- Venous Thromboembolism Prevention in Outpatients With GliomaRecruitingNCT05683808Phase 2
- Antisecretory Factor Glioblastoma Phase 2RecruitingNCT05669820Phase 2/3
- Glutamate Inhibitors in GlioblastomaRecruitingNCT05664464Phase 1/2
- CARv3-TEAM-E T Cells in GlioblastomaRecruitingNCT05660369Phase 1
- Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?Not yet recruitingNCT05656300
- Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II StudyRecruitingNCT05653635Phase 2
- Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated GlioblastomaRecruitingNCT05653622Phase 2
- Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.Not yet recruitingNCT05641220
- Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) PatientsRecruitingNCT05638451Phase 2
- Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep LearningRecruitingNCT05624736
- A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM MultiformeRecruitingNCT05600491Phase 3
- Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain TumorRecruitingNCT05590689Phase 1/2
- Tris-CAR-T Cell Therapy for Recurrent GlioblastomaRecruitingNCT05577091Phase 1
- Response Assessment During MR-guided Radiation Therapy for GlioblastomaRecruitingNCT05565326
- Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of ProgressionRecruitingNCT05565118Phase 1
- Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic BiomarkersNot yet recruitingNCT05541042
- Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent GlioblastomaNot yet recruitingNCT05540275Phase 2
- Personalized Trial in ctDNA-level-relapse GlioblastomaNot yet recruitingNCT05539339Not applicable
- Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma PatientsNot yet recruitingNCT05515133
- Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of GlioblastomaNot yet recruitingNCT05512195Not applicable
- Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse GlioblastomaNot yet recruitingNCT05502991Phase 2
- MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation TherapyRecruitingNCT05500612
- Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL TreatmentRecruitingNCT05460507Phase 1
- Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly GlioblastomaRecruitingNCT05439278Phase 3
- Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentRecruitingNCT05432804Phase 1/2
- Pilot Trial for Treatment of Recurrent GlioblastomaRecruitingNCT05432518Early Phase 1
- Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma MultiformeRecruitingNCT05423210Early Phase 1
- Functional and Ultrasound Guided Resection of GlioblastomaRecruitingNCT05399524Not applicable
- Registering Genomics and Imaging of Tumors (ReGIT)RecruitingNCT05386043
- Personalized Cancer Stem Cell High-Throughput Drug Screening for GlioblastomaRecruitingNCT05380349Early Phase 1
- Control Cohort CTRL COHRecruitingNCT05370079Not applicable
- Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3TcRecruitingNCT05366179Phase 1
- Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®RecruitingNCT05363826Phase 1
- Glioblastoma and Individualized TherapiesAvailableNCT05356312
- Vacuolar ATPase and Drug Resistance of High Grade GliomasRecruitingNCT05328089
- THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)RecruitingNCT05326334
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)RecruitingNCT05303519Phase 3
- A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMRecruitingNCT05303467Phase 1
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent GlioblastomaRecruitingNCT05284643Not applicable
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsRecruitingNCT05283330Phase 1
- Sonobiopsy for Noninvasive and Sensitive Detection of GlioblastomaRecruitingNCT05281731Not applicable
- Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMRecruitingNCT05271240Phase 3
- The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With PembrolizumabRecruitingNCT05235737Phase 4
- Ex VIvo DEtermiNed Cancer TherapyRecruitingNCT05231655
- Evaluation of the CONVIVO SystemRecruitingNCT05139277Not applicable
- Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade GliomasRecruitingNCT05139056Phase 1
- Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerRecruitingNCT05106296Phase 1
- AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBMNot yet recruitingNCT05100641Phase 3
- Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)RecruitingNCT05099068Not applicable
- A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive GlioblastomaNot yet recruitingNCT05095441Phase 1
- WBSI Guided Personalized Delivery of TTFieldsRecruitingNCT05086497Not applicable
- Study of Pembrolizumab and M032 (NSC 733972)RecruitingNCT05084430Phase 1/2
- Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With GlioblastomaRecruitingNCT05083754Phase 1
- hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)RecruitingNCT05052957Phase 2
- Individualized Systems Medicine Functional Profiling for Recurrent GlioblastomaRecruitingNCT05043701Early Phase 1
- Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent GlioblastomaRecruitingNCT04977375Phase 1/2
- A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBMNot yet recruitingNCT04967690Phase 1
- Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy TemozolomideRecruitingNCT04945148Phase 2
- CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)Not yet recruitingNCT04933422Phase 1
- BRiTE - Bispecific T Cell Engager for Patients With GlioblastomaRecruitingNCT04903795Phase 1
- Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent GlioblastomaRecruitingNCT04863950Phase 2
- Loupe-Based Intraoperative Fluorescence ImagingRecruitingNCT04780009
- Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM PatientsRecruitingNCT04765514Phase 2
- Tamoxifen Versus Etoposide After First Recurrence in GBM PatientsRecruitingNCT04765098Phase 2
- Glioblastoma Radiotherapy Using IMRT or Proton BeamsRecruitingNCT04752280Not applicable
- ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS TumorsRecruitingNCT04732065Phase 1